Publication

Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma: cohort a of magnetisMM-3

Shay, Gemma
; 
Bahlis, N
; 
Tomasson, MH
; 
Mohty, M
; 
Niesvizky, R
; 
Nooka, A
; 
Manier, S
; 
Maisel, C
; 
Jethava, Y
; 
Martinez-Lopez, J
... show 10 more
Citations
Altmetric:
Abstract
Authors
Shay, Gemma
Bahlis, N
Tomasson, MH
Mohty, M
Niesvizky, R
Nooka, A
Manier, S
Maisel, C
Jethava, Y
Martinez-Lopez, J
Prince, HM
Arnulf, B
Rodriguez-Otero, P
Koehne, G
Touzeau, C
Raje, N
Iida, S
Raab, MS
Leip, E
Sullivan, S
Conte, U
Viqueira, A
Lesokhin, A
Affiliation
The Christie Hospital, The University of Manchester, Manchester, UK
Description
Date
2023
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Shay G, Bahlis N, Tomasson MH, Mohty M, Niesvizky R, Nooka A, et al. Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma: Cohort a of MagnetisMM-3. British journal of haematology. 2023 APR;201:16-7. PubMed PMID: WOS:001049283000021. English.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/626707
Embedded videos